We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Cloned Nerve Cells Cure Parkinson's-Like Disease in Mice

By Biotechdaily staff writers
Posted on 08 Oct 2003
Researchers have found a novel way of producing therapeutic nerve cells that can cure mice with Parkinson's-like disease. More...
Their work was described in the September 21,2003, online issue of Nature Biotechnology.

An earlier study showed that unlimited numbers of genetically matched dopamine nerve cells would be generated by using cloned stem cells whose genetic material originated from the mouse's own tail. Dopamine neurons are the ones that are lost in patients with Parkinson's disease. However, this method worked for cells derived from some mice but not from others.

The researchers developed a better way of selectively generating dopamine neurons that eliminates variability in order for therapeutic cloning to work consistently for every animal. Using this new technique, the team differentiated stem cells into genetically matched neural cells in vitro. They were able to develop nerve cells specific to the forebrain, midbrain, hindbrain, and spinal cord, as well as supporting glial cells. The next step is to develop unique cell lines for a number of Parkinsonian mice and show that these cloned cells can cure each individual mouse.

"The new technique is a model system that will provide scientists with the opportunity to see how the brain develops in vitro, and conduct experiments such as observing in a culture dish the developmental consequences of disrupting single or multiple genes,” said senior author Lorenz Studer, M.D., head of the stem cell and tumor biology laboratory at Memorial Sloan-Kettering Cancer Center (MSKCC, New York, NY, USA; www.mskcc.org), who worked with a team of colleagues from MSKCC, Cornell University (New York, NY, USA), and the University of Connecticut (Storrs, USA).




Related Links:
Memorial Sloan-Kettering

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Automated Clinical Chemistry Analyzer
Envoy 500+
New
Benchtop Thermomixer
Biometra TS1 ThermoShaker
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Photo courtesy of Adobe Stock

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.